Strategic Partnership : The company announced its partnership with the National Institutes of Health (NIH) on the BRAIN ( B rain R esearch through A dvancing I nnovative N eurotechnologies) initiative to advance in neuroscience research. Positive study outcome s : Abbott has generated positive outcomes from several of its clinical trial studies, which have factors have driven the company's shares. It has announced positive data on the use of its FreeStyle Libre system, a revolutionary continuous glucose monitoring (CGM) technology.